Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The erythromycin breath test for the prediction of drug clearance.
Rivory LP, Slaviero KA, Hoskins JM, Clarke SJ. Rivory LP, et al. Among authors: hoskins jm. Clin Pharmacokinet. 2001;40(3):151-8. doi: 10.2165/00003088-200140030-00001. Clin Pharmacokinet. 2001. PMID: 11327195 Review.
Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
Wong M, Evans S, Rivory LP, Hoskins JM, Mann GJ, Farlow D, Clarke CL, Balleine RL, Gurney H. Wong M, et al. Among authors: hoskins jm. Clin Pharmacol Ther. 2005 Jan;77(1):33-42. doi: 10.1016/j.clpt.2004.09.002. Clin Pharmacol Ther. 2005. PMID: 15637529
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.
Wong M, Balleine RL, Blair EY, McLachlan AJ, Ackland SP, Garg MB, Evans S, Farlow D, Collins M, Rivory LP, Hoskins JM, Mann GJ, Clarke CL, Gurney H. Wong M, et al. Among authors: hoskins jm. J Clin Oncol. 2006 Jun 1;24(16):2448-55. doi: 10.1200/JCO.2005.02.1295. Epub 2006 May 1. J Clin Oncol. 2006. PMID: 16651648
Optimizing the erythromycin breath test for use in cancer patients.
Rivory LP, Slaviero K, Seale JP, Hoskins JM, Boyer M, Beale PJ, Millward MJ, Bishop JF, Clarke SJ. Rivory LP, et al. Among authors: hoskins jm. Clin Cancer Res. 2000 Sep;6(9):3480-5. Clin Cancer Res. 2000. PMID: 10999732 Clinical Trial.
Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population.
Hoskins JM, Shenfield GM, Gross AS. Hoskins JM, et al. Br J Clin Pharmacol. 1998 Nov;46(5):499-504. doi: 10.1046/j.1365-2125.1998.00807.x. Br J Clin Pharmacol. 1998. PMID: 9833604 Free PMC article.
Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype.
Gurney H, Wong M, Balleine RL, Rivory LP, McLachlan AJ, Hoskins JM, Wilcken N, Clarke CL, Mann GJ, Collins M, Delforce SE, Lynch K, Schran H. Gurney H, et al. Among authors: hoskins jm. Clin Pharmacol Ther. 2007 Jul;82(1):33-40. doi: 10.1038/sj.clpt.6100201. Epub 2007 May 9. Clin Pharmacol Ther. 2007. PMID: 17495881 Clinical Trial.
Concordance between proguanil phenotype and CYP2C19 genotype in Chinese.
Hoskins JM, Shenfield GM, Gross AS. Hoskins JM, et al. Eur J Clin Pharmacol. 2003 Nov;59(8-9):611-4. doi: 10.1007/s00228-003-0665-4. Epub 2003 Sep 12. Eur J Clin Pharmacol. 2003. PMID: 13680037 Clinical Trial.
Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping.
Hoskins JM, Shenfield GM, Gross AS. Hoskins JM, et al. J Chromatogr B Biomed Sci Appl. 1997 Aug 15;696(1):81-7. doi: 10.1016/s0378-4347(97)00225-9. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9300912
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
Sharma R, Hoskins JM, Rivory LP, Zucknick M, London R, Liddle C, Clarke SJ. Sharma R, et al. Among authors: hoskins jm. Clin Cancer Res. 2008 Feb 1;14(3):817-25. doi: 10.1158/1078-0432.CCR-07-0425. Clin Cancer Res. 2008. PMID: 18245544
UGT1A and irinotecan toxicity: keeping it in the family.
Hoskins JM, McLeod HL. Hoskins JM, et al. J Clin Oncol. 2009 May 20;27(15):2419-21. doi: 10.1200/JCO.2008.20.9478. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364959 No abstract available.
61 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback